THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK

Federal Trade Commission Workshop Highlights How Brand Name Drug Companies Read More

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS

Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In Read More

BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021

Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in Read More

ICYMI: ANALYSIS REVEALS IMPACT OF BIG PHARMA’S ANTI-COMPETITIVE PRACTICES AROUND INHALERS

Brand Name Drug Companies Prevent Competition from More Affordable Read More

BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS

Part D Spending on 10 Most Popular Medications Over Five Years Averages Five Read More

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER

Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After Read More

DOSE OF REALITY: SENATE COMMERCE HEARING OPPORTUNITY FOR LAWMAKERS TO HOLD BIG PHARMA ACCOUNTABLE

Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS, GLAXOSMITHKLINE, AMGEN, ROCHE

Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street Read More

CSRXP AD CAMPAIGN: AMERICAN PEOPLE HAVE WAITED LONG ENOUGH; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE

Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game Read More